Anxiety GAD-7

The first two Anxiety questions (Q18 and Q19) are called the Generalized Anxiety Disorder-2 (GAD-2). They are also the same first two question in the Generalized Anxiety Disorder-7 (GAD-7). GAD-7 is moderately good at screening for:

• General Anxiety Disorder (sensitivity 89%, specificity 82%) (Spitzer RL, Arch Intern Med. 2006; 166:1092-1097
• Panic Disorder (sensitivity 74%, specificity 81%) (Kroenke K, Spitzer RL, Williams JB, Ann Intern Med. 2007 Mar 6;146(5):317-25)
• Social Anxiety Disorder (sensitivity 72%, specificity 80%) (same source as above)
• PTSD (sensitivity 66%, specificity 81%) (same source as above)

Return to the CDC Health Risk Assessments or Patient Well-Being Assessment

Over the last 2 weeks, how often have you been bothered by the following problems?	Not at all	Several days	Over half the days	Nearly every day
1. Feeling nervous, anxious or on edge (Q18)	0	1	2	3
2. Not being able to stop or control worrying (Q19)	0	1	2	3
3. Worrying too much about different things	0	1	2	3
4. Trouble relaxing	0	1	2	3
5. Being so restless that it is hard to sit still	0	1	2	3
6. Becoming easily annoyed or irritable	0	1	2	3
7. Feeling afraid as if something awful might happen	0	1	2	3
Total the score	_____ +	_____ +	_____ +	_____
			=Total Score	_____

If you checked off any problems, how difficult have these problems made it for you to do your work, take care of things at home, or get along with other people?
□ Not difficult at all
□ Somewhat difficult
□ Very difficult
□ Extremely difficult

Interpreting GAD-7 Scores

Diagnosis	Total Score	For Score	Suggested Action
Mild Anxiety Moderate Anxiety	0-5 6-10	≤ 4	The score suggests the patient may not need depression treatment
Mild depression Moderate depression	5-9 10-14	5-14	Physician uses clinical judgement about treatment, based on patient's duration of symptoms and functional impairment
Moderately severe depression Severe depression	15-19 20-27	> 14	Warrants treatment for depression, using antidepressant, psychotherapy and/or combination of treatment

The PHQ-9 is described in more detail at the Pfizer website.